Seeking Alpha

PRGO
Perrigo Company

5/26/2012, 9:38 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
PRGO Market Currents more »
  • May 18 Perrigo (PRGO -0.2%) has received final FDA approval for its abbreviated new drug application for Lansoprazole capsules for the treatment of frequent heartburn. Shipments of the product to customers have already begun. This new product for the U.S. store brand market is the equivalent to Novartis' (NVS) Prevacid 24 hour capsules.
    Comment!
    [Healthcare]
PRGO in Focus more »
PRGO Instablog posts more »
  • Barchart Morning Call 5/8
    Tue, May 8 • Jim Van Meerten • Comment!
  • 12 Healthcare Dividend Stocks With Gaining Earnings Momentum
    Mon, Apr 2 • Dividend Sheet • Comment!
  • SeekingAlpha Experiment: Stocks For March
    Mon, Mar 5 • Jeff Gonion • Comment!
  • The SeekingAlpha Experiment: February Results
    Mon, Mar 5 • Jeff Gonion • Comment!
  • Market Rises On Better Economic Data: SPX, Nasdaq, GS, JPM, WYNN, LVS, AAPL, PCLN, ISRG, PRGO, CRM, VMW, CTXS, RHT, LULU, SINA, QIHU, YOKU, BIDU
    Thu, Mar 1 • MyHappyTrading • Comment!
Write a post on PRGO
PRGO StockTalks
PRGO vs. ETF Alternatives
Company Description

Perrigo Company, established in 1887, is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic... More